Current Approach to Hepatocellular Carcinoma

被引：51

作者：

Abrams, Peter ^{[1
]}

Marsh, J. Wallis ^{[1
]}

机构：

[1] Univ Pittsburgh, Montefiore Hosp, Sch Med, Dept Surg,Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15215 USA

来源：

SURGICAL CLINICS OF NORTH AMERICA | 2010年 / 90卷 / 04期

关键词：

Hepatocellular carcinoma; Partial hepatectomy; Liver transplantation; Locoregional therapy; Transartenal chemoembolization; Radiofrequency ablation; PERCUTANEOUS RADIOFREQUENCY ABLATION; PRESERVED LIVER-FUNCTION; SURGICAL RESECTION; ADJUVANT THERAPY; WAITING-LIST; RISK-FACTORS; TRANSARTERIAL CHEMOEMBOLIZATION; INTRAHEPATIC RECURRENCE; MULTIVARIATE-ANALYSIS; CIRRHOTIC-PATIENTS;

D O I：

10.1016/j.suc.2010.04.010

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Hepatocellular carcinoma (HCC) accounts for 80% of all primary liver cancers and ranks globally as the fourth leading cause of cancer-related death Partial hepatectomy remains the best treatment option for select patients with HCC without cirrhosis Liver transplantation is well established as the gold standard for patients with HCC and cirrhosis in the absence of extrahepatic spread and macrovascular invasion. Local regional therapy is indicated in select patients who are not surgical candidates, and its role as adjuvant therapy remains to be clarified by prospective studies

引用

收藏

页码：803 / +

页数：15

相关论文

共 72 条

[1] RISK-FACTORS FOR INTRAHEPATIC RECURRENCE IN HUMAN SMALL HEPATOCELLULAR-CARCINOMA [J].

ADACHI, E ;

MAEDA, T ;

MATSUMATA, T ;

SHIRABE, K ;

KINUKAWA, N ;

SUGIMACHI, K ;

TSUNEYOSHI, M .

GASTROENTEROLOGY, 1995, 108 (03) :768-775

[2]

American Liver Tumor Study Group, 1998, RAND PROSP MULT TRIA

[3] Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan [J].

Arii, S ;

Yamaoka, Y ;

Futagawa, S ;

Inoue, K ;

Kobayashi, K ;

Kojiro, M ;

Makuuchi, M ;

Nakamura, Y ;

Okita, K ;

Yamada, R .

HEPATOLOGY, 2000, 32 (06) :1224-1229

[4] NATURAL-HISTORY OF SMALL UNTREATED HEPATOCELLULAR-CARCINOMA IN CIRRHOSIS - A MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS OF TUMOR-GROWTH RATE AND PATIENT SURVIVAL [J].

BARBARA, L ;

BENZI, G ;

GAIANI, S ;

FUSCONI, F ;

ZIRONI, G ;

SIRINGO, S ;

RIGAMONTI, A ;

BARBARA, C ;

GRIGIONI, W ;

MAZZIOTTI, A ;

BOLONDI, L .

HEPATOLOGY, 1992, 16 (01) :132-137

[5] Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival [J].

Bharat, Ankit ;

Brown, Daniel B. ;

Crippin, Jeffrey S. ;

Gould, Jennifer E. ;

Lowell, Jeffrey A. ;

Shenoy, Surendra ;

Desai, Niraj M. ;

Chapman, William C. .

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (04) :411-420

[6] LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].

BISMUTH, H ;

CHICHE, L ;

ADAM, R ;

CASTAING, D ;

DIAMOND, T ;

DENNISON, A .

ANNALS OF SURGERY, 1993, 218 (02) :145-151

[7] Management of hepatoceullular carcinoma [J].

Bruix, J ;

Sherman, M .

HEPATOLOGY, 2005, 42 (05) :1208-1236

[8] Liver transplantation for hepatocellular carcinoma: foucault pendulum versus evidence-based decision [J].

Bruix, J ;

Fuster, J ;

Llovet, JM .

LIVER TRANSPLANTATION, 2003, 9 (07) :700-702

[9] Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure [J].

Bruix, J ;

Castells, A ;

Bosch, J ;

Feu, F ;

Fuster, J ;

GarciaPagan, JC ;

Visa, J ;

Bru, C ;

Rodes, J .

GASTROENTEROLOGY, 1996, 111 (04) :1018-1022

[10] Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].

Bruix, J ;

Sherman, M ;

Llovet, JM ;

Beaugrand, M ;

Lencioni, R ;

Burroughs, AK ;

Christensen, E ;

Pagliaro, L ;

Colombo, M ;

Rodés, J .

JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430

← 1 2 3 4 5 6 7 8 →